A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia.
about
A practical algorithm for managing Alzheimer's disease: what, when, and why?Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease.Real-world evaluation of compliance and preference in Alzheimer's disease treatment.Rivastigmine in moderately severe-to-severe Alzheimer's disease: Severe Impairment Battery factor analysis.Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.Recent Progress in the Pharmacotherapy of Alzheimer's Disease.An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine.The cholinergic system in the pathophysiology and treatment of Alzheimer's diseaseStrategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents
P2860
Q26859831-43F662DB-8B07-4A8E-82DF-E76AEDDDA4E6Q33596451-B0988C6F-4391-4DFB-818E-C46B3DB8B535Q36165980-84663218-30B6-4C9A-BCC2-FB61FA152EB0Q36264977-7ABA7F18-2FDE-40B7-B344-79EF0914625EQ37690174-2B3FDA4A-7AF0-4807-B4EB-D2F90729F6BAQ38350602-9C313B28-1A9D-41BE-8668-5FF6C05170A6Q47425364-884DA043-581D-4500-90C5-F8688587B86FQ50328399-95979A17-FF3C-4E2C-9D48-B12A55CA8D08Q57177786-6E7348CA-A337-486A-823F-6DEA8F27128DQ58794595-FE7ABF12-2477-40A1-BEE7-1B57D7BF546F
P2860
A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@ast
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@en
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@nl
type
label
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@ast
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@en
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@nl
prefLabel
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@ast
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@en
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@nl
P2093
P2860
P356
P1476
A 24-week, randomized, control ...... n severe Alzheimer's dementia.
@en
P2093
Carl H Sadowsky
George T Grossberg
Martin R Farlow
Monique Somogyi
Xiangyi Meng
P2860
P304
P356
10.1111/CNS.12158
P407
P577
2013-08-07T00:00:00Z